DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced its forecast for fiscal 2010 revenue growth to be in the range of 17% to 25% over fiscal year 2009, or approximately $86 million to $91 million.
